Although the elevated adiponectin level in patients with CKD is reported to play a protective role against atherosclerosis and cardiovascular diseases [35, 36], it is currently unknown whether the elevated CTRP9 levels in subjects with CKD play a role or are merely due to reduced renal excretion. Here, ADIPOQ is linked to atherosclerosis.